Lenalidomide: A Life-Saving Drug for Cancer Treatment
Lenalidomide, a derivative of thalidomide, has emerged as a cornerstone in the treatment of various hematological malignancies, particularly multiple myeloma and certain types of lymphoma. Approved by the U.S. Food and Drug Administration (FDA) in 2005, It has transformed cancer care, significantly improving survival rates and quality of life for many patients. Its unique mechanism…